| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2013-07-05 | MGN1703 (lefitolimod) | advanced colorectal cancer |
2 | Mologen (Germany) | Cancer - Oncology |
| 2013-07-02 | Syn1002 | pain | 1b | CLL Pharma (France) Leurquin-Mediolanum (France) | CNS diseases |
| 2013-07-01 | LR769 (recombinant form of human Factor VIIa - rhFVIIa) | hemophilia A and B |
2 | rEVO Biologics (USA - MA), an LFB Company (France) | Genetic diseases- Hematological diseases |
| 2013-06-27 | omalizumab | moderate to severe refractory chronic idiopathic/spontaneous urticaria (CIU/CSU) |
3 | Novartis (Switzerland) Genentech, a member of Roche group (USA - Switzerland) | Dermatological diseases - Inflammatory diseases |
| 2013-06-27 | PXL-01 | prevention of post-surgical adhesions | 2 | Pergamum (Sweden) | |
| 2013-06-25 | gevokizumab (XOMA 052/S 78989) | polymyositis/dermatomyositis |
POC study | Servier (France) Xoma (USA - CA) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2013-06-24 | albiglutide | type 2 diabetes | 3 | GSK (UK) | Metabolic diseases |
| 2013-06-22 | ZP-GA-1 (glucagon analogue) | preclinical data | Zealand Pharma (Denmark) | Metabolic diseases | |
| 2013-06-21 | ALX-0761 | inflammatory diseases |
1 | Merck Serono (Germany) | Inflammatory diseases |
| 2013-06-20 | PRX-110 | cystic fibrosis (CF) |
preclinical | Protalix BioTherapeutics (Israel) | Rare diseases - Genetic diseases |
| 2013-06-20 | PRX-107 | emphysema from heredity alpha-1 antitrypsin deficiency (AATD) |
Protalix BioTherapeutics (Israel) | Respiratory diseases - Genetic diseases - Rare diseases | |
| 2013-06-19 | Debio 0617B | preclinical | Aurigene (India) Debiopharm Group (Switzerland) | Cancer - Oncology | |
| 2013-06-19 | safinamide | Parkinson's disease | 3 | Newron Pharmaceuticals (Italy) Zambon (Italy) | Neurodegenerative diseases - CNS diseases |
| 2013-06-17 | Somatuline® Autogel® (lanreotide) 120mg | newly diagnosed acromegaly patients with a macroadenoma | 3b | Ipsen (France) | Rare diseases - Hormonal diseases - Endocrine diseases |
| 2013-06-17 | MCLA-117 | acute myeloid leukemia (AML) | 1 | Merus (The Netherlands) | Cancer - Oncology |
| 2013-06-17 | SMT19969 | infections caused by Clostridium difficile | 1 | Summit (UK) | Infectious diseases |
| 2013-06-14 | sNN0031 | Parkinson’s disease | Newron Pharmaceuticals (Italy) | Neurodegenerative diseases - CNS diseases | |
| 2013-06-14 | Methylene Blue MMX® | polyp and adenoma detection rate in patients undergoing full colonoscopy colon cancer diagnosis |
3 | Cosmo Pharmaceuticals (Italy) | Cancer - Oncology |
| 2013-06-13 | Agenmestencel-T (genetically modified, adult mesenchymal stem cells) | advanced adenocarcinomas of the gastrointestinal tract | 1-2 | apceth (Germany) | Cancer - Oncology |
| 2013-06-13 | Tykerb/Tyverb® (lapatinib) | HER2-positive advanced gastric cancer |
3 | GSK (UK) | Cancer - Oncology |
